A decrease in TGF-β levels makes the individual susceptible to autoimmune lymphocytic inflammation while its administration in autoimmune disorders, in which T-cells have a prominent role, might have a therapeutic effect.14,16. This evidence concerns the gene TGFB1 and autoimmune disease.